Do the survivin (BIRC5) splice variants modulate or add to the prognostic value of total survivin in breast cancer?

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Clinical Chemistry

• Publication date

  2006-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1373/CLINCHEM.2006.071613PMID 16873289
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular Analysis of Survivin Isoforms

  2006cited by this paper
• A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer

  2006cited by this paper
• High survivin predicts a poor response to endocrine therapy, but a good response to chemotherapy in advanced breast cancer

  2006cited by this paper
• Survivin splice variants regulate the balance between proliferation and cell death

  2005cited by this paper
• Normalization of gene expression measurements in tumor tissues: comparison of 13 endogenous control genes

  2005cited by this paper
• Regulation of apoptosis by alternative pre-mRNA splicing.

  2005cited by this paper
• Nuclear or cytoplasmic expression of survivin: What is the significance?

  2005cited by this paper
• Distinct expression of Survivin splice variants in breast carcinomas.

  2005cited by this paper
• Survivin 2α: a novel Survivin splice variant expressed in human malignancies

  2005cited by this paper
• Expression of survivin and its splice variants survivin-2B and survivin-ΔEx3 in breast cancer

  2004influential reference
• A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer.

  2004cited by this paper
• Survivin is an independent prognostic marker for risk stratification of breast cancer patients.

  2004cited by this paper
• Identification of a novel splice variant of the human anti-apoptopsis gene survivin.

  2004cited by this paper
• Lack of prognostic significance of survivin, survivin-deltaEx3, survivin-2B, galectin-3, bag-1, bax-alpha and MRP-1 mRNAs in breast cancer.

  2003influential reference
• Validating survivin as a cancer therapeutic target

  2003cited by this paper
• Prognostic importance of survivin in breast cancer

  2003cited by this paper
• Differential subcellular localization of functionally divergent survivin splice variants

  2002cited by this paper
• Expression of survivin and its relationship to loss of apoptosis in breast carcinomas.

  2000cited by this paper
• Survivin-deltaEx3 and survivin-2B: two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties.

  1999cited by this paper
• Analysis of human transcriptomes

  1999cited by this paper
• A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma

  1997cited by this paper

• The prognostic role of survivin expression in breast cancer: A systematic review and meta-analysis

  2024cites this paper
• BIRC5 expression by race, age and clinical factors in breast cancer patients

  2024cites this paper
• Altered Expression of Survivin Variants S-2B and S-WT in Breast Cancer Is Related to Adipokine Expression

  2022cites this paper
• Thorough statistical analyses of breast cancer co-methylation patterns

  2021cites this paper
• Altered expression of survivin and its splice variants ∆Ex3 and 2B contributes to disease development in breast cancer

  2019cites this paper
• Menadione Induced Apoptosis in MKN45 Cells via Down-regulation of Survivin

  2019cites this paper
• Clinical, morphological, and molecular genetic predictors of metastatic lesions in the regional lymph nodes in breast cancer

  2018cites this paper
• Expression of Survivin and Its Splice Variants in Pediatric Acute Lymphoblastic Leukemia

  2018cites this paper
• Down-regulation of anti-apoptotic genes in tumor cell lines is facilitated by suppression of OCT4B1.

  2017cites this paper
• Survivin isoform expression in arsenic trioxide‐treated acute promyelocytic leukemia cell line and patients: The odd expression pattern of survivin‐2α

  2017cites this paper
• BIRC5 Genomic Copy Number Variation in Early-Onset Breast Cancer

  2016cites this paper
• EVALUATION THE EXPRESSION OF THREE GENES TO EPITHELIAL OVARIAN CANCER RISK IN CHINESE POPULATION

  2016cites this paper
• A Study of Gene Expression of Survivin, its Antiapoptotic Variants, and Targeting Survivin In Vitro for Therapy in Retinoblastoma

  2016cites this paper
• Survivin Overexpression Is Associated with Aggressive Clinicopathological Features in Cervical Carcinoma: A Meta-Analysis

  2016cites this paper
• Survivin splice variants and their diagnostic significance

  2015cites this paper
• High expression of survivin and its splice variants survivin ΔEx3 and survivin 2 B in oral cancers.

  2015cites this paper
• Survinin expression in patients with breast cancer during chemotherapy

  2015cites this paper
• Prognostic Significance of Survivin in Breast Cancer: Meta‐analysis

  2014cites this paper
• Integrated analysis of expression profiling data identifies three genes in correlation with poor prognosis of triple-negative breast cancer.

  2014cites this paper
• Association of survivin splice variants with prognosis and treatment of breast cancer.

  2014cites this paper
• Die Expression von Survivin und seine Relevanz für die Cisplatin-Resistenz von Keimzelltumoren

  2014cites this paper
• Validation of a real-time quantitative polymerase chain reaction method for the quantification of 3 survivin transcripts and evaluation in breast cancer tissues.

  2014cites this paper
• Survivin and YM155: how faithful is the liaison?

  2014cites this paper
• Clinico-pathologic relevance of Survivin splice variant expression in cancer.

  2013influential citation
• Prognostic value of survivin expression in breast cancer patients: a meta-analysis

  2013cites this paper
• Expression of survivin and its four splice variants in colorectal cancer and its clinical significances

  2013cites this paper
• Transcriptional Expression Analysis of Survivin Splice Variants Reveals Differential Expression of Survivin-3α in Breast Cancer

  2013influential citation
• Imatinib increases apoptosis index through modulation of survivin subcellular localization in the blast phase of CML cells.

  2012cites this paper
• Survivin expression and targeting in breast cancer.

  2012cites this paper
• Survivin splice variants are not essential for mitotic progression or inhibition of apoptosis induced by doxorubicin and radiation

  2012cites this paper
• YM 155 , a selective survivin suppressant , inhibits tumor spread and prolongs survival in a spontaneous metastatic model of human triple negative breast cancer

  2011cites this paper
• Apoptosis gene signature of Survivin and its splice variant expression in breast carcinoma.

  2011cites this paper
• The role of survivin in diagnosis, prognosis and treatment of breast cancer.

  2011influential citation
• YM155, a selective survivin suppressant, inhibits tumor spread and prolongs survival in a spontaneous metastatic model of human triple negative breast cancer.

  2011cites this paper
• The survivin -31 snp in human colorectal cancer correlates with survivin splice variant expression and improved overall survival

  2011cites this paper
• Tithonia diversifolia and its main active component tagitinin C induce survivin inhibition and G2/M arrest in human malignant glioblastoma cells.

  2011cites this paper
• Expression and prognostic significance of survivin splice variants in diffusely infiltrating astrocytoma

  2011cites this paper
• Toward an Alzheimer's disease diagnosis via high‐resolution blood gene expression

  2010cites this paper
• Differential regulation of TP73 isoforms by 1α,25‐dihydroxyvitamin D3 and survivin in human colon and breast carcinomas

  2010cites this paper
• The Survivin −31 Snp in Human Colorectal Cancer Correlates with Survivin Splice Variant Expression and Improved Overall Survival

  2010cites this paper
• Commentary on “Developing a national strategy to prevent dementia: Leon Thal Symposium 2009.” Developing a blood test for Alzheimer's disease using advanced genomic expression technology

  2010cites this paper
• مطالعهی بیان ژنSurvivin و واریانتهای پیرایشی ΔEx3٬ 2b و 3b آن به عنوان تومور مارکرهای تشخیصی در سرطان پستان

  2009cites this paper
• Survivin is expressed in early hepatocellular carcinoma and surrounding hepatitis tissue.

  2009cites this paper
• Predictive value of survivin alternative transcript expression in locally advanced breast cancer patients treated with neoadjuvant chemotherapy.

  2009cites this paper
• Survivin and its spliced isoform gene expression is associated with proliferation of renal cancer cells and clinical stage of renal cancer.

  2009cites this paper
• Molecular prediction of early recurrence after resection of hepatocellular carcinoma.

  2009cites this paper
• STUDY OF THE EXPRESSION OF SURVIVIN & ITS SPLICE VARIANTS; Δ EX3, 2B AND 3B AS DIAGNOSTIC MOLECULAR MARKERS IN BREAST CANCER

  2009cites this paper
• IAP-targeted therapies for cancer

  2008cites this paper
• Prediction of Metastasis and Recurrence of Breast Carcinoma: Detection of Survivin-Expressing Circulating Cancer Cells

  2008cites this paper
• Gene expression of survivin and its spliced isoforms associated with proliferation and aggressive phenotypes of prostate cancer.

  2008cites this paper
• Survivin: a promising tumor biomarker.

  2007cites this paper
• Population-Based Molecular Prognosis of Breast Cancer by Transcriptional Profiling

  2007cites this paper
• Relationship between survivin expression and recurrence, and prognosis in hepatocellular carcinoma.

  2007cites this paper
• Proteome informatics for cancer research: From molecules to clinic

  2007cites this paper
• Are overexpressed alternative survivin transcripts in human bladder cancer suitable targets for siRNA-mediated in vitro inhibition?

  2007cites this paper
• Expression of survivin and its splice variants in gastric cancer

  2007cites this paper